Question Bank › Geographic or market replication just started wo

Geographic or market replication just started working outside the home base

Calls Tested
500
Answered YES
34
Hit Rate
6.8%
rare by design

Pfizer Inc. (PFE) — this company's answers

NO on the Q4 2023 call 2024-01-30 F
The model's full reasoning — Q4 2023 call → NO我们根据提供的电话会议记录来判断。问题问的是管理层是否描述了“在原始市场或环境中已被证明的业务最近开始在新领域产生实际结果”，并且这些新领域的结果是早期且正在扩张的。 在记录中，管理层提到了多个产品，但我们需要寻找一个清晰的模式：一个在原始市场（或环境）中已确立的业务，最近在新领域（地理或不同市场）开始产生实际结果，且这些新领域仍占公司业务的小部分，但早期结果支持进一步扩张。 检查记录内容： - 关于Prevnar（肺炎球菌疫苗），管理层提到在美国，成人市场已经“耗尽”了追赶机会，而儿科市场正在增长。在国际市场，产品刚刚推出，正在获得推荐。但这里没有明确说“新领域”是最近开始产生实际结果，且国际业务可能不是“新领域”而是已有业务。 - 关于Abrysvo（RSV疫苗），管理层提到在成人疫苗方面，市场份额低于预期，但正在努力改善零售合同。在母体疫苗方面，刚刚推出几个月，但“受到鼓舞”。这可能是新领域，但母体疫苗是新产品，不是“已证明的业务”在新领域复制。 - 关于Nurtec，管理层提到在美国和全球的处方增长，但这是同一市场。 - 关于Oxbryta，管理层提到美国表现良好，但“世界其他地区”是收入的一小部分，需要时间发展。这似乎符合：Oxbryta在美国已证明，但国际是新的，且目前很小。但管理层没有具体说国际最近开始产生实际结果，只是说“需要时间发展”。 - 关于Comirnaty，管理层提到国际合同，但那是疫苗，且是季节性。 更仔细地看，问题要求“同一已证明的提供物现在在第二个地方实际运作”。在记录中，有一个明显的例子：关于Prevnar，管理层说“在国际市场，我们刚刚推出，并且正在获得推荐”，但这是否是“最近开始产生实际结果”？管理层提到“我们继续在儿科和成人方面取得进展”，但具体数字没有给出。另外，关于Abrysvo的母体疫苗，是新产品，不是“已证明的业务”。 另一个可能：关于Vyndaqel，管理层提到在日本诊断率低，但那是现有市场。 我认为没有明确的管理层描述符合这个模式。管理层没有说“我们在新领域最近开始产生实际收入，且这是早期阶段”。他们更多是在讨论现有产品的市场动态。 因此，答案应为NO。

← Back to the full PFE analysis

Show the exact prompt the model was given
Using ONLY the supplied earnings call transcript and no outside information: On this call, does management describe that a business already proven in the company's ORIGINAL market, territory, or setting has RECENTLY begun producing REAL RESULTS IN NEW TERRITORY — additional regions, countries, markets, or settings the company has recently entered — with management presenting the away-from-home results as early evidence that the proven model travels, while the new territories remain a small share of the company today? Answer YES when management's own words convey, in whatever form fits the business, ONE coherent pattern with all three present: (1) A HOME-PROVEN BASE: the company has an established, working business in its original market or setting, treated by management as demonstrated rather than in question; (2) AWAY RESULTS NOW REAL AND RECENT: in the recent period, the new territories or markets are actually transacting — real customers, orders, revenue, openings, volumes, or usage happening there now, described with concrete substance and recency, not merely entered, announced, or staffed; and (3) EARLY AND EXPANDING: management conveys that the new-territory contribution is still a small part of the company, that the early results support pressing further, and that continued expansion is underway or committed — so the reported results reflect mostly the home business while the replication is just beginning to layer on top. The territory may be geographic or a genuinely distinct market or setting; what matters is the same proven offering now demonstrably working in a second place. Answer NO if the away expansion is only planned, announced, or pre-revenue. NO if new territories are already the bulk of the business. NO if the away results are one immaterial anecdote. NO if expansion is chiefly by acquisition just consolidated rather than the company's own model replicating. NO if the home business itself is failing and expansion is escape. NO if the pattern appears only in an analyst's question management does not affirm. Use only the supplied transcript. Answer only YES or NO.

Companies that answered YES

TickerCompanyCallDateCall grade
ASO Academy Sports and Outdoors, Inc. Q1 2024 2024-06-11 C+
LINC Lincoln Educational Services Corporation Q1 2024 2024-05-06 B+
GRBK Green Brick Partners, Inc. Q3 2023 2023-11-01 B
FSBC Five Star Bancorp Q3 2023 2023-10-31 B
TGLS Tecnoglass Inc. Q2 2023 2023-08-08 A
PTLO Portillo's Inc. Q2 2023 2023-08-05 B
PFIE Profire Energy, Inc. Q1 2023 2023-05-13 B
M Macy's, Inc. Q4 2022 2023-03-02 D
ADPT Adaptive Biotechnologies Corporation Q4 2022 2023-02-14 C+
HBB Hamilton Beach Brands Holding Company Q3 2022 2022-11-05 C
SYY Sysco Corporation Q1 2023 2022-11-01 C+
HLNE Hamilton Lane Incorporated Q1 2023 2022-08-02 C+
OGI OrganiGram Holdings Inc. Q3 2022 2022-07-14 B+
SE Sea Limited Q1 2022 2022-05-17 F
ADSE ADS-TEC Energy PLC Q4 2021 2022-04-28 D
SOPH SOPHiA GENETICS SA Q4 2021 2022-03-15 C
RELY Remitly Global, Inc. Q4 2021 2022-03-02 B
VNDA Vanda Pharmaceuticals Inc. Q4 2021 2022-02-23 F
GTES Gates Industrial Corporation plc Q4 2021 2022-02-07 C+
MOMO Hello Group Inc. Q3 2021 2021-11-30 D
SXC SunCoke Energy, Inc. Q3 2021 2021-11-01 A
LOPE Grand Canyon Education, Inc. Q2 2021 2021-08-08 C
UFI Unifi, Inc. Q4 2021 2021-08-07 B
TENB Tenable Holdings, Inc. Q2 2021 2021-07-27 A
SATS EchoStar Corporation Q1 2018 2018-05-10 C+
INST Instructure's Q4 2017 2018-02-12 B+
HOLX Hologic, Inc. Q4 2017 2017-11-08 D
IR Ingersoll-Rand Plc Q3 2017 2017-10-25 B
BIIB Biogen Inc. Q2 2017 2017-07-25 B
CNS Cohen & Steers, Inc. Q2 2017 2017-07-20 B
KHC The Kraft Heinz Company Q1 2017 2017-05-03 F
SHOO Steven Madden, Ltd. Q1 2017 2017-04-21 C
MDLZ Mondelez International, Inc. Q4 2016 2017-02-07 C
GOGO Gogo Inc. Q1 2016 2016-05-06 C+

How the model reasoned

RELY · Q4 2021 → YESThe question is about whether management describes a business proven in the original market that has recently begun producing real results in new territories, with those new territories still a small ...YES The transcript shows management describing a home-proven base in the US (original market), with away-from-home results in new territories (outside the US) now real and recent—$120 million revenue in 2021, up from $58 million in 2020, across expanded corridors (over 2, 100 total, with 700+ new last year). These new territories remain a minority share at 26% of total revenue, described as early-stage investments supporting long-term growth via localization in unlaunched geographies, with the model replicating through the same playbook.
LOPE · Q2 2021 → YESThe question is about whether management describes a business proven in the original market that has recently begun producing real results in new territory, with all three elements: home-proven base, ...NO The transcript shows Orbis as an acquired business (29 months ago) that management is now expanding through new partnerships and sites in additional territories. This does not meet the criteria because the expansion is chiefly by acquisition and consolidation rather than the company's own model replicating independently in new territories. The away results are real and recent 4,210 enrollments up 13.2%, but the pattern does not fully align with the required home-proven base and early expanding replication of the original model.
TENB · Q2 2021 → YESThe question is about whether management describes a business proven in the original market that has recently begun producing real results in new territories, with those new territories still a small ...YES Management describes a home-proven base in traditional IT/VM, with recent real results in OT (six-figure cross-sell win at a large public utility, early deployments successful) and AD (early stages with successful traction), plus EMEA outperformance. These new settings remain small contributions today, with management framing 2024 investments as support for continued expansion of the proven model.

More from the question bank

Regular buyers moved from occasional to progNamed counterparty roster suddenly upgraded Management describes competitors unable to rThe economics improved before the volume arrThe company's product is being consumed fastConstraint-side candorAll questions →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.